Mustafa M. Ahmed , Holly Grant , Jasmine Martinez , Joshua Thomas , Mohammad Al-Ani , Alex Parker , Juan Vilaro , Juan Aranda , Venkat Keshav Chivukula
{"title":"患者特异性血流动力学建模以优化左室辅助器速度和右心健康","authors":"Mustafa M. Ahmed , Holly Grant , Jasmine Martinez , Joshua Thomas , Mohammad Al-Ani , Alex Parker , Juan Vilaro , Juan Aranda , Venkat Keshav Chivukula","doi":"10.1016/j.jhlto.2024.100190","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Left ventricular assist device (LVAD) speed optimization and right heart failure post device implantation are major clinical challenges. Right heart catheterization (RHC)–guided speed titration studies are often performed to optimize LVAD settings, which are unknown and must be optimized for each patient. A virtual hemodynamic model (VHM) that can be tailored to each patient may provide useful guidance and reduce repeated studies.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis on 16 patients implanted with HeartMate 3 (HM3) who underwent RHC speed titration study as an outpatient. A custom-designed VHM was built and customized for each patient based on RHC measurements. VHM predictions were obtained for multiple scenarios: (1) population–based pulmonary system parameters, (2) patient-specific systemic and pulmonary resistance and capacitance parameters, (3) clinical optimization–based patient-specific mean arterial pressure (MAP), and (4) several MAP targets ranging from 70 to 90 mm Hg.</div></div><div><h3>Results</h3><div>All patients who underwent RHC speed titration had a clinician–guided speed increase, with a median increase of 300 revolutions per minute (rpm). Using each patient’s customized VHM, virtual speed optimization demonstrated congruence with clinician-guided optimization, with a median predicted speed increase of 321 rpm. After virtual optimization, there was a decrease in the pulmonary artery pressure for 13 patients (81.25%), indicating a predicted improvement in pulmonary parameters.</div></div><div><h3>Conclusions</h3><div>For our cohort of 16 patients, there was an overall congruence between clinician–guided and patient–specific VHM-predicted optimal LVAD speeds. The magnitude of speed change varied depending on individual patient targets. This may provide individualized speed titration goals and lessen the need for repeat invasive studies.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"7 ","pages":"Article 100190"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient–specific hemodynamic modeling to optimize LVAD speed and right heart health\",\"authors\":\"Mustafa M. Ahmed , Holly Grant , Jasmine Martinez , Joshua Thomas , Mohammad Al-Ani , Alex Parker , Juan Vilaro , Juan Aranda , Venkat Keshav Chivukula\",\"doi\":\"10.1016/j.jhlto.2024.100190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Left ventricular assist device (LVAD) speed optimization and right heart failure post device implantation are major clinical challenges. Right heart catheterization (RHC)–guided speed titration studies are often performed to optimize LVAD settings, which are unknown and must be optimized for each patient. A virtual hemodynamic model (VHM) that can be tailored to each patient may provide useful guidance and reduce repeated studies.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis on 16 patients implanted with HeartMate 3 (HM3) who underwent RHC speed titration study as an outpatient. A custom-designed VHM was built and customized for each patient based on RHC measurements. VHM predictions were obtained for multiple scenarios: (1) population–based pulmonary system parameters, (2) patient-specific systemic and pulmonary resistance and capacitance parameters, (3) clinical optimization–based patient-specific mean arterial pressure (MAP), and (4) several MAP targets ranging from 70 to 90 mm Hg.</div></div><div><h3>Results</h3><div>All patients who underwent RHC speed titration had a clinician–guided speed increase, with a median increase of 300 revolutions per minute (rpm). Using each patient’s customized VHM, virtual speed optimization demonstrated congruence with clinician-guided optimization, with a median predicted speed increase of 321 rpm. After virtual optimization, there was a decrease in the pulmonary artery pressure for 13 patients (81.25%), indicating a predicted improvement in pulmonary parameters.</div></div><div><h3>Conclusions</h3><div>For our cohort of 16 patients, there was an overall congruence between clinician–guided and patient–specific VHM-predicted optimal LVAD speeds. The magnitude of speed change varied depending on individual patient targets. This may provide individualized speed titration goals and lessen the need for repeat invasive studies.</div></div>\",\"PeriodicalId\":100741,\"journal\":{\"name\":\"JHLT Open\",\"volume\":\"7 \",\"pages\":\"Article 100190\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHLT Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950133424001393\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133424001393","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景左心室辅助装置(LVAD)的速度优化和装置植入后的右心衰是主要的临床挑战。右心导管(RHC)引导下的速度滴定研究通常用于优化LVAD设置,这些设置是未知的,必须针对每个患者进行优化。虚拟血流动力学模型(VHM)可以为每个患者量身定制,可以提供有用的指导并减少重复研究。方法回顾性分析16例门诊接受心脏伴侣3 (HeartMate 3, HM3)植入患者的RHC快速滴定研究。根据每位患者的RHC测量值,建立并定制了定制设计的VHM。在多种情况下获得了VHM预测:(1)基于人群的肺系统参数,(2)患者特异性全身和肺阻力和电容参数,(3)基于临床优化的患者特异性平均动脉压(MAP),以及(4)70至90 mm hg的几个MAP目标。结果所有接受RHC速度滴定的患者都有临床指导的速度增加,中位数增加300转/分钟(rpm)。使用每个患者定制的VHM,虚拟速度优化与临床指导的优化一致,中位数预测速度增加321 rpm。虚拟优化后,13例(81.25%)患者肺动脉压下降,预示肺参数改善。在我们的16例患者队列中,在临床指导和患者特异性vhm预测的最佳LVAD速度之间存在总体一致性。速度变化的幅度取决于个体患者的目标。这可能提供个性化的速度滴定目标,并减少重复侵入性研究的需要。
Patient–specific hemodynamic modeling to optimize LVAD speed and right heart health
Background
Left ventricular assist device (LVAD) speed optimization and right heart failure post device implantation are major clinical challenges. Right heart catheterization (RHC)–guided speed titration studies are often performed to optimize LVAD settings, which are unknown and must be optimized for each patient. A virtual hemodynamic model (VHM) that can be tailored to each patient may provide useful guidance and reduce repeated studies.
Methods
We conducted a retrospective analysis on 16 patients implanted with HeartMate 3 (HM3) who underwent RHC speed titration study as an outpatient. A custom-designed VHM was built and customized for each patient based on RHC measurements. VHM predictions were obtained for multiple scenarios: (1) population–based pulmonary system parameters, (2) patient-specific systemic and pulmonary resistance and capacitance parameters, (3) clinical optimization–based patient-specific mean arterial pressure (MAP), and (4) several MAP targets ranging from 70 to 90 mm Hg.
Results
All patients who underwent RHC speed titration had a clinician–guided speed increase, with a median increase of 300 revolutions per minute (rpm). Using each patient’s customized VHM, virtual speed optimization demonstrated congruence with clinician-guided optimization, with a median predicted speed increase of 321 rpm. After virtual optimization, there was a decrease in the pulmonary artery pressure for 13 patients (81.25%), indicating a predicted improvement in pulmonary parameters.
Conclusions
For our cohort of 16 patients, there was an overall congruence between clinician–guided and patient–specific VHM-predicted optimal LVAD speeds. The magnitude of speed change varied depending on individual patient targets. This may provide individualized speed titration goals and lessen the need for repeat invasive studies.